Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
16 new stocks listed on the Beijing Stock Exchange, with an average first-day increase of 160%
In the first quarter of 2026, a total of 16 new stocks were listed on the Beijing Stock Exchange, establishing itself as the undeniable main battlefield for IPOs. Data from Wind shows that the 16 newly listed stocks averaged a gain of 160% on their first day of trading, reflecting continued high levels of market momentum. At the same time, the review process has been accelerated across the board: within the year, 34 companies have successfully passed the review, and hard-tech companies have become a key highlight. Combined with a batch of soon-to-be-launched new stocks such as Saiying Electronics and Chenguang Electric Machinery, the Beijing Stock Exchange is forming a positive cycle of “a batch to be listed, a batch to pass review, and a batch to be launched,” driven by dual engines of market expansion and quality improvement.
Since the beginning of this year, the issuance pace of new stocks on the Beijing Stock Exchange has clearly accelerated. Sixteen companies have successively gone public, covering emerging-productive-force tracks such as advanced equipment, new materials, biomedical, and industrial internet. Among them, 13 are National-level “Specialized, Refined, Unique, and New” “little giants.”
In terms of market performance, Zu Xing New Materials led the way with a first-day gain of 405.73%. The company has long focused on the R&D, production, and sales of micro-fine spherical aluminum powder and aluminum pigments. As of early March 2026, Zu Xing New Materials has accumulated 90 authorized patents. Its products have already fully reached the level of imported products in key indicators such as batch uniformity and stability, and even surpass them in certain aspects. These products are widely used in extremely demanding areas such as high-end automobiles, 3C electronics, and aerospace, where material performance requirements are particularly strict.
Recently listed Xin Hengtai, Puang Medical, and Yuelong Technology also all saw first-day gains that doubled.
Among them, Yuelong Technology focuses on the R&D, production, and sales of flexible piping for fluid transport. Its core products cover three major series of rubber hoses: ocean engineering, onshore oil and gas, and industrial use. With nearly ten thousand models, they can meet the needs of extreme operating conditions such as high temperatures, high pressures, and corrosion, breaking foreign technology monopolies and achieving high-end domestic substitution.
Puang Medical specializes in the R&D, production, and sales of diabetes care, general drug delivery infusion, and minimally invasive interventional medical devices. The company is a domestic enterprise and one of the earliest in the Chinese market to launch needles for safe automatic self-destruction injection pens.
Since 2026, the Beijing Stock Exchange’s review of new stocks has also noticeably accelerated. It is no longer uncommon to see three companies go to the meeting in a single week, and there was even a case in which five companies passed the review in one week. Overall, this year has seen 34 companies pass the review. Many of these companies have hard-tech attributes.
The newly reviewed Rui Electronics, which successfully passed the review on April 3, is one example. The company’s main business is the R&D, production, and sales of industrial robot (300024) control systems and components, as well as servo systems and components. It is a National-level “Specialized, Refined, Unique, and New” “little giant” enterprise, a Zhejiang Province “Specialized, Refined, Unique, and New” small and medium-sized enterprise, and a National High-Tech Enterprise. Its proposed IPO fundraising amounts to 139.69M yuan, to be used for the production center upgrade and renovation project, the R&D center construction project, and supplementing working capital.
Baiying Biotech, which passed the review on March 31, is a CRO company focused on antibody and protein expression, antibody discovery and optimization. The company has expanded from antibody and protein expression business to antibody discovery and optimization business, aiming to provide customers with one-stop antibody discovery services. At the same time, it is also actively opening up overseas markets, with the share of overseas business rising year by year.
At present, there are a total of four companies in the issuance stage: Chenguang Electric Machinery, Saiying Electronics, Hengdao Technology, and Chuangda New Materials.
Among them, Chenguang Electric Machinery is scheduled to be listed on April 8. Chenguang Electric Machinery focuses on the R&D, production, and sales of micro motors. Its products are mainly used in the cleaning appliance sector dominated by vacuum cleaners. The products have been applied to well-known domestic and international cleaning appliance brands such as Bissell, Shark, Whirlpool (600983), Philips, Panasonic, Xiaomi, and Midea.
(Editor-in-charge: Zhang Yan)
Report